Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium for Allergen Induced Early Asthmatic Responses
NCT04648813Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Nov 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic asthma comparing Tiotropium Sequence with Placebo Sequence (2 arms). Primary endpoint: Early Asthmatic Response PD20. Started Nov 2020; status: completed.
02
Drugs
tiotropium
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT04648813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04648813.